AbstractGlycogen storage disease type Ia (GSD-Ia) patients deficient in glucose-6-phosphatase-α manifest a disturbed glucose homeostasis. We hypothesized that disturbed glucose homeostasis might affect myeloid functions. Here, we show that GSD-Ia mice exhibit normal neutrophil activities but have elevated myeloid progenitor cells in the bone marrow and spleen. Interestingly, GSD-Ia mice exhibit a persistent increase in peripheral blood neutrophil counts along with elevated serum levels of granulocyte colony stimulating factor and cytokine-induced neutrophil chemoattractant. Taken together, our results suggest that a loss of glucose homeostasis can compromise the immune system, resulting in neutrophilia. This may explain some of the unexpect...
Background: In GSDIa, glucose 6-phosphate (G6P) accumulates in the endoplasmic reticulum (ER); in GS...
Objective: Glycogen storage disease type 1a (GSD Ia) is a rare inherited metabolic disorder caused b...
International audienceIt is a long-standing enigma how glycogen storage disease (GSD) type I patient...
AbstractGlycogen storage disease type Ia (GSD-Ia) patients deficient in glucose-6-phosphatase-α mani...
Glycogen storage disease type Ib (GSD-Ib), characterized by impaired glucose homeostasis, neutropeni...
Glycogen storage disease type 1b (GSD 1b) is caused by mutations in the Glucose-6-phosphate transpor...
Glycogen storage disease (GSD) is a rare autosomal-recessive disorder characterized by hypoglycemia,...
Background and aims: Glycogen storage disease type Ib (GSD1b) is a rare metabolic and immune disorde...
Glycogen storage disease (GSD) 1b is a metabolic disorder characterized by a deficiency of glucose 6...
Glycogen storage disease type 1a (GSD 1a) is caused by a deficiency in microsomal glucose-6-phosphat...
SummaryGlycogen-storage disease type 1 (GSD-1), also known as “von Gierke disease,” is caused by a d...
Background: In GSDIa, glucose 6-phosphate (G6P) accumulates in the endoplasmic reticulum (ER); in GS...
Background: In GSDIa, glucose 6-phosphate (G6P) accumulates in the endoplasmic reticulum (ER); in GS...
Objective: Glycogen storage disease type 1a (GSD Ia) is a rare inherited metabolic disorder caused b...
International audienceIt is a long-standing enigma how glycogen storage disease (GSD) type I patient...
AbstractGlycogen storage disease type Ia (GSD-Ia) patients deficient in glucose-6-phosphatase-α mani...
Glycogen storage disease type Ib (GSD-Ib), characterized by impaired glucose homeostasis, neutropeni...
Glycogen storage disease type 1b (GSD 1b) is caused by mutations in the Glucose-6-phosphate transpor...
Glycogen storage disease (GSD) is a rare autosomal-recessive disorder characterized by hypoglycemia,...
Background and aims: Glycogen storage disease type Ib (GSD1b) is a rare metabolic and immune disorde...
Glycogen storage disease (GSD) 1b is a metabolic disorder characterized by a deficiency of glucose 6...
Glycogen storage disease type 1a (GSD 1a) is caused by a deficiency in microsomal glucose-6-phosphat...
SummaryGlycogen-storage disease type 1 (GSD-1), also known as “von Gierke disease,” is caused by a d...
Background: In GSDIa, glucose 6-phosphate (G6P) accumulates in the endoplasmic reticulum (ER); in GS...
Background: In GSDIa, glucose 6-phosphate (G6P) accumulates in the endoplasmic reticulum (ER); in GS...
Objective: Glycogen storage disease type 1a (GSD Ia) is a rare inherited metabolic disorder caused b...
International audienceIt is a long-standing enigma how glycogen storage disease (GSD) type I patient...